Himpharm AO in Consumer Health (Kazakhstan)

September 2016 | 2 pages | ID: H4B9911C00FEN
Euromonitor International Ltd

Abstracts

By the end of 2017, local pharmaceuticals manufacturer Himpharm AO plans to double its profits. During 2016 and 2017, the company is set to launch nine new products. Furthermore, it is expected that, from 2017, the company will begin the production of consumer health products at its new factory located in the southern Kazakh city of Shymkent. The production capacity of the new factory is 24 million bottles of consumer health products per year.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
  Summary 1 Himpharm AO: Key Facts
  Summary 2 Himpharm AO: Operational Indicators
Competitive Positioning
  Summary 3 Himpharm AO: Competitive Position 2016